Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes

Towards Raman-Based Screening of Acute Lymphoblastic Leukemia-Type B (B-ALL) Subtypes

Acute lymphoblastic leukemia (ALL) is the most common type of malignant neoplasms in the pediatric population. B-cell precursor ALLs (BCP-ALLs) are derived from the progenitors of B lymphocytes. Traditionally, risk factors stratifying therapy in ALL patients included age at diagnosis, initial leukoc...

Full description

Bibliographic Details
Main Authors:	Patrycja Leszczenko, Aleksandra Borek-Dorosz, Anna Maria Nowakowska, Adriana Adamczyk, Sviatlana Kashyrskaya, Justyna Jakubowska, Marta Ząbczyńska, Agata Pastorczak, Kinga Ostrowska, Malgorzata Baranska, Katarzyna Maria Marzec, Katarzyna Majzner
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Cancers
Subjects:	Raman spectroscopy acute lymphoblastic leukemia (ALL) fusion genes chemometric techniques <i>BCR-ABL1</i> <i>TCF-PBX1</i>
Online Access:	https://www.mdpi.com/2072-6694/13/21/5483

Similar Items

Molecular <i>BCR::ABL1</i> Quantification and <i>ABL1</i> Mutation Detection as Essential Tools for the Clinical Management of Chronic Myeloid Leukemia Patients: Results from a Brazilian Single-Center Study
by: Anelis Maria Marin, et al.
Published: (2023-06-01)

In <i>BCR-ABL1</i> Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
by: Elisa Buzzatti, et al.
Published: (2022-03-01)

Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients
by: Stefania Stella, et al.
Published: (2022-04-01)

Karakteristik Klinis Pasien Leukemia Limfoblastik Akut (LLA) dengan Fusi Gena TELAML1, BCR-ABL, dan E2A-PBX1
by: Sri Mulatsih, et al.
Published: (2016-11-01)

IDENTIFICATION OF MOLECULAR ALTERATIONS IN VENEZUELAN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA DIAGNOSIS
by: Y.C. Castro, et al.
Published: (2020-07-01)

Future Approaches for Treating Chronic Myeloid Leukemia: CRISPR Therapy
by: Elena Vuelta, et al.
Published: (2021-02-01)

Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction
by: Jan Kulis, et al.
Published: (2022-07-01)

Kill Two Birds with One Stone: A Multifunctional Dual‐Targeting Protein Drug to Overcome Imatinib Resistance in Philadelphia Chromosome‐Positive Leukemia
by: Bohan Ma, et al.
Published: (2022-05-01)

The Screening of microRNAs in Chronic Myeloid Leukemia: A Clinical Evaluation
by: Denise Kusma Wosniaki, et al.
Published: (2024-03-01)

CircRNAome of Childhood Acute Lymphoblastic Leukemia: Deciphering Subtype-Specific Expression Profiles and Involvement in <i>TCF3::PBX1</i> ALL
by: Angela Gutierrez-Camino, et al.
Published: (2024-01-01)

Deciphering Potential Molecular Signatures to Differentiate Acute Myeloid Leukemia (AML) with <i>BCR::ABL1</i> from Chronic Myeloid Leukemia (CML) in Blast Crisis
by: Lara Boucher, et al.
Published: (2023-10-01)

Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing
by: Arti Easwar, et al.
Published: (2021-10-01)

Genetic Screening for Potential New Targets in Chronic Myeloid Leukemia Based on Drosophila Transgenic for Human BCR-ABL1
by: Marco Lo Iacono, et al.
Published: (2021-01-01)

Raman-based spectrophenotyping of the most important cells of the immune system
by: Aleksandra Borek-Dorosz, et al.
Published: (2022-11-01)

<i>Sphagneticola Trilobata</i> (L.) Pruski (Asteraceae) Methanol Extract Induces Apoptosis in Leukemia Cells through Suppression of BCR/ABL
by: Hoang Thanh Chi, et al.
Published: (2021-05-01)

Impact of BCR-ABL1 Transcript Type on Response, Treatment-Free Remission Rate and Survival in Chronic Myeloid Leukemia Patients Treated with Imatinib
by: Sílvia Marcé, et al.
Published: (2021-07-01)

The Giant HECT E3 Ubiquitin Ligase HERC1 Is Aberrantly Expressed in Myeloid Related Disorders and It Is a Novel BCR-ABL1 Binding Partner
by: Muhammad Shahzad Ali, et al.
Published: (2021-01-01)

Underexpression of LINC00173 in TCF3/PBX1-Positive Cases Is Associated With Poor Prognosis in Children With B-Cell Precursor Acute Lymphoblastic Leukemia
by: Didier Ismael May-Hau, et al.
Published: (2022-06-01)

A Novel System for Semiautomatic Sample Processing in Chronic Myeloid Leukaemia: Increasing Throughput without Impacting on Molecular Monitoring at Time of SARS-CoV-2 Pandemic
by: Stefania Stella, et al.
Published: (2021-08-01)

Isolated monocytosis was the flag preceding abnormalities in other parameters of complete blood counts in chronic myeloid leukemia with e1a2 (minor, P190) chimeric transcripts
by: Jae Won Yun, et al.
Published: (2019-03-01)

Diagnosis- and Prognosis-Related Gene Alterations in <i>BCR::ABL1</i>-Negative Myeloproliferative Neoplasms
by: Soji Morishita, et al.
Published: (2023-08-01)

Preclinical Evaluation of a Novel Small Molecule Inhibitor of LIM Kinases (LIMK) CEL_Amide in Philadelphia-Chromosome Positive (<i>BCR::ABL+</i>) Acute Lymphoblastic Leukemia (ALL)
by: Jeannig Berrou, et al.
Published: (2022-11-01)

Overcoming Bcr-Abl T315I mutation by combination of GNF-2 and ATP competitors in an Abl-independent mechanism
by: Khateb Mamduh, et al.
Published: (2012-11-01)

Cardiotoxicity of Tyrosine Kinase Inhibitors in Philadelphia-Positive Leukemia Patients
by: Adriatik Berisha, et al.
Published: (2023-02-01)

Droplet Digital PCR for <i>BCR–ABL1</i> Monitoring in Diagnostic Routine: Ready to Start?
by: Maria Teresa Bochicchio, et al.
Published: (2021-10-01)

Transcripto BCR-ABL atípico en un paciente con leucemia mieloide crónica Atypical BCR-ABL transcript in a patient with chronic myeloid leukemia
by: Ana María Amor Vigil, et al.
Published: (2011-09-01)

Effect of Plumbagin on growth inhibition and apoptosis of imatinib-resistant chronic myeloid leukemia
by: Bui Thi Kim Ly, et al.
Published: (2017-08-01)

Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis
by: Pablo Romero-Morelos, et al.
Published: (2024-02-01)

Gene Expression Pattern of <em>ESPL1</em>, <em>PTTG1</em> and <em>PTTG1IP</em> Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML
by: Eva Christiani, et al.
Published: (2023-05-01)

e14a2 Transcript Favors Treatment-Free Remission in Chronic Myeloid Leukemia When Associated with Longer Treatment with Tyrosine Kinase Inhibitors and Sustained Deep Molecular Response
by: Sílvia Marcé, et al.
Published: (2024-01-01)

Novel Multiplex Droplet Digital PCR Assays to Monitor Minimal Residual Disease in Chronic Myeloid Leukemia Patients Showing Atypical <i>BCR-ABL1</i> Transcripts
by: Jessica Petiti, et al.
Published: (2020-05-01)

Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
by: Simona Soverini, et al.
Published: (2021-06-01)

Dedifferentiation of B-lymphoblastic leukemia/lymphoma with t(9;22) BCR::ABL1 to an undifferentiated neoplasm with strong keratin expression in a patient receiving blinatumomab
by: Krasimira A. Rozenova, et al.
Published: (2023-03-01)

Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
by: Daisuke Ikeda, et al.
Published: (2022-05-01)

An interesting case of chronic myeloid leukemia (CML) with T315I mutation raising suspicion of de novo AML, a diagnostic conundrum
by: Phool Iqbal, et al.
Published: (2023-05-01)

Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
by: Mian Afsar, et al.
Published: (2012-09-01)

A study to determine the clinical, hematological, cytogenetic, and molecular profile in CML patient in and around Eastern UP, India
by: Sandip Kumar, et al.
Published: (2019-01-01)

Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report
by: Abdulsamad Wafa, et al.
Published: (2017-04-01)

Genetic features of B‐cell lymphoblastic lymphoma with TCF3‐PBX1
by: Ryota Shirai, et al.
Published: (2022-09-01)

Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma
by: Kshama Gupta, et al.
Published: (2022-05-01)